Follow
João Agostinho Machado-Neto
João Agostinho Machado-Neto
Department of Pharmacology, Institute of Biomedical Sciences of the University of São Paulo, Brazil
Verified email at usp.br
Title
Cited by
Cited by
Year
ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells
M Lazarini, F Traina, JA Machado-Neto, KSA Barcellos, YB Moreira, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (2), 365-374, 2013
732013
ARHGAP21 protein, a new partner of α-tubulin involved in cell-cell adhesion formation and essential for epithelial-mesenchymal transition
KSA Barcellos, CL Bigarella, MV Wagner, KP Vieira, M Lazarini, ...
Journal of Biological Chemistry 288 (4), 2179-2189, 2013
572013
Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia
MP Colella, EV De Paula, N Conran, JA Machado-Neto, ...
Journal of Thrombosis and Haemostasis 10 (9), 1967-1970, 2012
542012
Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells
JA Machado-Neto, P Favaro, M Lazarini, FF Costa, STO Saad, F Traina
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (8), 1404-1411, 2011
512011
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
P de Melo Campos, JA Machado-Neto, R Scopim-Ribeiro, V Visconte, ...
Leukemia research 38 (10), 1245-1251, 2014
502014
ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
JA Machado-Neto, M Lazarini, P Favaro, GC Franchi Jr, AE Nowill, ...
Experimental cell research 324 (2), 137-145, 2014
502014
Stathmin 1 in normal and malignant hematopoiesis
JA Machado-Neto, STO Saad, F Traina
BMB reports 47 (12), 660, 2014
492014
FMNL1 promotes proliferation and migration of leukemia cells
P Favaro, F Traina, JA Machado-Neto, M Lazarini, MR Lopes, ...
Journal of leukocyte biology 94 (3), 503-512, 2013
492013
Elevated hypercoagulability markers in hemoglobin SC disease
MP Colella, EV de Paula, JA Machado-Neto, N Conran, ...
haematologica 100 (4), 466, 2015
472015
DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy
LC de Almeida, FA Calil, JA Machado-Neto, LV Costa-Lotufo
Cancer Genetics 252, 6-24, 2021
432021
Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis
JA Machado-Neto, BA Fenerich, APN Rodrigues Alves, JC Fernandes, ...
Clinics 73 (Suppl 1), e566s, 2018
422018
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
MR Lopes, JKN Pereira, P de Melo Campos, JA Machado-Neto, F Traina, ...
Scientific reports 7 (1), 40707, 2017
392017
Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells
JA Machado-Neto, P de Melo Campos, P Favaro, M Lazarini, ...
Leukemia research 38 (1), 251-257, 2014
382014
ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells
JA Machado-Neto, M Lazarini, P Favaro, P de Melo Campos, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (3), 583-593, 2015
352015
Serine peptidase inhibitor Kunitz type 2 (SPINT2) in cancer development and progression
FM Roversi, STO Saad, JA Machado-Neto
Biomedicine & Pharmacotherapy 101, 278-286, 2018
342018
ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells
A Dhyani, ASS Duarte, JA Machado-Neto, P Favaro, MM Ortega, ...
FEBS letters, 2012
342012
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
JKN Pereira, JA Machado-Neto, MR Lopes, BC Morini, F Traina, FF Costa, ...
European Journal of Cancer, 2015
312015
IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells
APNR Alves, JC Fernandes, BA Fenerich, JL Coelho-Silva, PS Scheucher, ...
Cancer Letters 456, 59-68, 2019
302019
IL10 inversely correlates with the percentage of CD8+ cells in MDS patients
MR Lopes, F Traina, PM Campos, JKN Pereira, JA Machado-Neto, ...
Leukemia Research, 2013
302013
NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells
BA Fenerich, JC Fernandes, APN Rodrigues Alves, JL Coelho-Silva, ...
Signal Transduction and Targeted Therapy 5, 5, 2020
292020
The system can't perform the operation now. Try again later.
Articles 1–20